Start: Wednesday, June 3, 2026 - 01:00 pm
End: Wednesday, June 3, 2026 - 04:00 pm
End: Wednesday, June 3, 2026 - 04:00 pm
Categories:
Public Notices
North Dakota Drug Use Review Board
Wednesday, June 3, 2026
1- 4 p.m. CT
In-Person Information
HHS Hoteling Space, Room 308, Judicial Wing, State Capitol
600 E. Boulevard Ave., Bismarck, ND 58505
Virtual Information
Join by computer: Join meeting here
Join by phone: 701-328-0950, Conference ID #248 378 348 242 80
Agenda
- Call to Order
- Roll Call
- Review and Approval of Minutes
- Reports from Department
- Administrative Report: Cost of Dispensing Survey, Website Overview
- Financial Report: Top Drugs
- Retrospective Drug Utilization Review (DUR) Report
- Clinical Report: Prior Authorization and Criteria Updates: Alzheimer’s, Heart Failure, Imcivree, & Mounjaro
- Special Orders: Presiding Officer and Vice-Presiding Officer Elections
- Unfinished Business
- Aqvesme, Ozempic for Type 1 diabetes and chronic kidney disease, Leqembi renewal criteria, Sapropterin non-responsive after 1 month at 20 mg/kg
- New Business
- Second Reviews of Acromegaly, Calcium Channel Blockers, Graft vs Host Disease, Malaria
- First Reviews of Familial Chylomicronemia Syndrome, Nausea and Vomiting, Thrombotic Microangiopathies (TMA)
- Review of Retrospective DUR Criteria Recommendations
- Provider suggestions for clinical practice education or Retrospective Drug Utilization Review (RDUR) Incremental Cost-Effectiveness Ratio (ICER) criteria
- Announcements: Next Meeting (September 9, 2026)
- Adjourn
Individuals who need accommodations in order to participate or who would like information about joining the meeting can contact Ashley Gerving at 701-328-2354, 711 (TTY) or gervingashley@nd.gov.
Date Posted: 12/12/2025
Date Revised: 05/27/2026 (agenda/meeting details added)